Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis

Inclusion Criteria: * Children of either sex and any race aged 6 to 18 years * History of seasonal allergic conjunctivitis lasting at least 1 allergy season (including patients with rhinoconjunctivitis and atopic dermatitis) * Current complaint of itching and conjunctival redness in both eyes * Positive skin reaction to at least one common local grass pollen, including Gramineae, at screening or in the 12 months before the study Exclusion Criteria: * Another previous or ongoing ocular disorder * Presence of significant corneal involvement * Sensitivity to any component of the study medications * Use of medication between 1 week before the study and study completion that could confound the interpretation of results (i.e. antihistamines, corticosteroids, nonsteroidal anti-inflammatory drugs, mast cell stabilizers, topical ocular vasoconstrictors) * Participation in other pharmacologic studies during the month before the study * Poor baseline visual acuity (not correctable to ≥ 0.6 logMAR in both eyes) * Autoimmune disease associated with dry eye syndrome (eg, rheumatoid arthritis) * Inability to discontinue wearing contact lenses during the study * Inability to discontinue the use of concomitant medication: immunosuppressive drugs, sulfa- or neomycin-containing antibiotics, antibiotics causing allergic reaction